Boston Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.7M | Buy |
543,169
+11,738
| +2% | +$879K | 0.05% | 271 |
|
|
2025
Q1 | $33.4M | Sell |
531,431
-4,831
| -0.9% | -$304K | 0.04% | 266 |
|
|
2024
Q4 | $41.5M | Buy |
536,262
+115,506
| +27% | +$8.94M | 0.05% | 253 |
|
|
2024
Q3 | $33.5M | Sell |
420,756
-4,250
| -1% | -$338K | 0.04% | 270 |
|
|
2024
Q2 | $35.7M | Sell |
425,006
-19,174
| -4% | -$1.61M | 0.04% | 265 |
|
|
2024
Q1 | $38.3M | Sell |
444,180
-263,254
| -37% | -$22.7M | 0.05% | 267 |
|
|
2023
Q4 | $60.4M | Sell |
707,434
-24,168
| -3% | -$2.06M | 0.08% | 237 |
|
|
2023
Q3 | $65.1M | Sell |
731,602
-27,990
| -4% | -$2.49M | 0.09% | 228 |
|
|
2023
Q2 | $65.1M | Buy |
759,592
+95,928
| +14% | +$8.23M | 0.09% | 218 |
|
|
2023
Q1 | $54.9M | Buy |
663,664
+147,440
| +29% | +$12.2M | 0.08% | 219 |
|
|
2022
Q4 | $41M | Buy |
516,224
+216,210
| +72% | +$17.2M | 0.06% | 231 |
|
|
2022
Q3 | $22.6M | Sell |
300,014
-9,006
| -3% | -$678K | 0.03% | 280 |
|
|
2022
Q2 | $20.3M | Buy |
309,020
+5,495
| +2% | +$361K | 0.03% | 308 |
|
|
2022
Q1 | $19.1M | Buy |
303,525
+2,937
| +1% | +$185K | 0.02% | 326 |
|
|
2021
Q4 | $15.9M | Sell |
300,588
-4,621
| -2% | -$245K | 0.02% | 335 |
|
|
2021
Q3 | $21.5M | Sell |
305,209
-2,273
| -0.7% | -$160K | 0.03% | 316 |
|
|
2021
Q2 | $20.4M | Buy |
+307,482
| New | +$20.4M | 0.03% | 320 |
|
|
2018
Q3 | – | Sell |
-20,005
| Closed | -$1.79M | – | 736 |
|
|
2018
Q2 | $1.79M | Buy |
+20,005
| New | +$1.79M | ﹤0.01% | 676 |
|